Actuate Therapeutics clinical trials we track

Check company identity source

Phase 2 2 trials

TrialDrugs studiedStatusPrimary completion
9-ING-41 in Patients With Advanced CancersNCT036788839-ING-41, Carboplatin., Doxorubicin., Gemcitabine - 21 day cycle and 5 moreActive not recruiting2026-06Estimated
Actuate 1901: 9-ING-41 in MyelofibrosisNCT042180719-ING-41, RuxolitinibCompleted2022-10-13Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters